These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11033518)

  • 1. [Charcot Marie Tooth disease: exacerbation in pregnancy].
    Gastaut JL; Benaim J; Livet MO; Philip N
    Rev Neurol (Paris); 2000 Oct; 156(10):890-1. PubMed ID: 11033518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbation of Charcot-Marie-tooth disease in pregnancy.
    Pollock M; Nukada H; Kritchevsky M
    Neurology; 1982 Nov; 32(11):1311-4. PubMed ID: 6890171
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical, electrophysiological and molecular genetic studies in a family with X-linked dominant Charcot-Marie-Tooth neuropathy presenting a novel mutation in GJB1 Promoter and a rare polymorphism in LITAF/SIMPLE.
    Beauvais K; Furby A; Latour P
    Neuromuscul Disord; 2006 Jan; 16(1):14-8. PubMed ID: 16373087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy in Charcot-Marie-Tooth disease.
    Basu A; Al-Shenar S; Ray S
    J Obstet Gynaecol; 2006 May; 26(4):370. PubMed ID: 16753695
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuropathy progression in Charcot-Marie-Tooth disease type 1A.
    Shy ME; Chen L; Swan ER; Taube R; Krajewski KM; Herrmann D; Lewis RA; McDermott MP
    Neurology; 2008 Jan; 70(5):378-83. PubMed ID: 18227419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathologic fracture of the tibia associated with Charcot-Marie-Tooth disease].
    Quintart C; Baillon JM; Libotte M
    Acta Orthop Belg; 1999 Mar; 65(1):105-8. PubMed ID: 10217011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidural analgesia for labour in a patient with Charcot-Marie-Tooth disease.
    Scull T; Weeks S
    Can J Anaesth; 1996 Nov; 43(11):1150-2. PubMed ID: 8922772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charcot-Marie-Tooth disease impairs quality of life: why? And how do we improve it?
    Shy ME; Rose MR
    Neurology; 2005 Sep; 65(6):790-1. PubMed ID: 16186514
    [No Abstract]   [Full Text] [Related]  

  • 9. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.
    Passage E; Norreel JC; Noack-Fraissignes P; Sanguedolce V; Pizant J; Thirion X; Robaglia-Schlupp A; Pellissier JF; Fontés M
    Nat Med; 2004 Apr; 10(4):396-401. PubMed ID: 15034573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor tolerability of high dose ascorbic acid in a population of genetically confirmed adult Charcot-Marie-Tooth 1A patients.
    Toth C
    Acta Neurol Scand; 2009 Aug; 120(2):134-8. PubMed ID: 19154534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anesthetic management of a parturient with neurofibromatosis 1 and Charcot-Marie-Tooth disease.
    Kapur S; Kumar S; Eagland K
    J Clin Anesth; 2007 Aug; 19(5):405-6. PubMed ID: 17869996
    [No Abstract]   [Full Text] [Related]  

  • 12. Bilateral sudden sensorineural hearing loss caused by Charcot-Marie-Tooth disease.
    Papadakis CE; Hajiioannou JK; Kyrmizakis DE; Bizakis JG
    J Laryngol Otol; 2003 May; 117(5):399-401. PubMed ID: 12803792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease.
    Hoff JM; Gilhus NE; Daltveit AK
    Neurology; 2005 Feb; 64(3):459-62. PubMed ID: 15699375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease course of Charcot-Marie-Tooth disease type 2 and comorbidity.
    Gemignani F; Marbini A
    Arch Neurol; 2004 Sep; 61(9):1470; author reply 1470. PubMed ID: 15364699
    [No Abstract]   [Full Text] [Related]  

  • 15. Congenital pes cavus in a Charcot-Marie-tooth disease type 1A newborn.
    Fusco C; Frattini D; Scarano A; Giustina ED
    Pediatr Neurol; 2009 Jun; 40(6):461-4. PubMed ID: 19433282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characteristics of gait in Charcot-Marie-Tooth disease types I and II.
    Newman CJ; Walsh M; O'Sullivan R; Jenkinson A; Bennett D; Lynch B; O'Brien T
    Gait Posture; 2007 Jun; 26(1):120-7. PubMed ID: 17010610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series.
    Carter GT; Han JJ; Mayadev A; Weiss MD
    Am J Hosp Palliat Care; 2006; 23(5):412-6. PubMed ID: 17060310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of the cavus foot. Deformity in the pediatric patient with Charcot-Marie-Tooth.
    Olney B
    Foot Ankle Clin; 2000 Jun; 5(2):305-15. PubMed ID: 11232232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild early onset axonal Charcot-Marie-Tooth disease not linked to other axonal Charcot-Marie-Tooth loci.
    Kochanski A; Kennerson M; Kawulak M; Ryniewicz B; Rowinska-Marcinska K; Walizada G; Nowakowski A; Hausmanowa-Petrusewicz I; Nicholson GA
    Neurology; 2005 Feb; 64(3):533-5. PubMed ID: 15699389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charcot-Marie-Tooth disease: electrophysiology, molecular genetics and clinical management.
    Carter GT; England JD; Chance PF
    IDrugs; 2004 Feb; 7(2):151-9. PubMed ID: 15057660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.